newswire

Senzo Secures a $2mm Pre-Series A Financing Led by Bioadvance to Progress Its Breakthrough Lateral Flow Diagnostic Testing Platform for Covid-19, Flu A/B, Tuberculosis, HIV

Funds will be used to bring the Amplified Lateral Flow (ALF) COVID-19 at-home rapid test through regulatory approval and to market, increase manufacturing capabilities, and advance the development of ...
newswire

Senzo Adds Veteran Healthcare CEO Jeremy Stackawitz to Accelerate Commercialization of Senzo's Products Including a COVID Rapid Testing Breakthrough

PHILADELPHIA, October 26, 2021 (Newswire.com) - Senzo, a leading pre-commercial stage diagnostics company, is pleased to announce the confirmation of Jeremy Stackawitz as CEO. Stackawitz joins Senzo ...
Yahoo Finance

Senzo's Revolutionary Amplified Lateral Flow (ALF) Platform Delivers Rapid COVID-19 Test Exactly Matching PCR Results in 3rd-Party Study by the University of Sheffield

PHILADELPHIA, May 31, 2022 (GLOBE NEWSWIRE) -- Senzo, an innovative point-of-care and self-testing diagnostics company, is announcing 100% accuracy of its revolutionary Amplified Lateral Flow (ALF) ...
Yahoo Finance

It's the era of at-home health diagnostics and Senzo is finding its flow

Biotech company Senzo just raised a $2 million round at a $20 million pre-money valuation to further extend options for lateral flow diagnostics. "Lateral flow," in this case, is the same type of ...
TechCrunch

It’s the era of at-home health diagnostics and Senzo is finding its flow

Biotech company Senzo just raised a $2 million round at a $20 million pre-money valuation to further extend options for lateral flow diagnostics. “Lateral flow,” in this case, is the same type of ...